Clinical Trials List
2014-08-09 - 2024-10-15
Phase III
Terminated6
-
Trial Applicant
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- 林璟宏 Division of Hematology & Oncology
- 張端瑩 Division of Hematology & Oncology
- 郭文宏 Division of General Surgery
- MING-YANG WANG Division of General Surgery
- YEN-SHEN LU Division of Hematology & Oncology
- 林柏翰 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Chi-Chang Yu Division of General Surgery
- 張潤忠 Division of Radiology
- 沈士哲 Division of General Surgery
- Wen-Chi Shen Division of Hematology & Oncology
- Hsien-Kun Chang Division of Hematology & Oncology
- Yung-Chang Lin Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Ta-Chung Chao Division of General Surgery
- 王國鐘 Division of General Surgery
- 金光亮 Division of General Surgery
- 賴亦貞 Division of Radiology
- Chun-Yu Liu Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Chieh-Han Chuang Division of General Surgery
- 甘蓉瑜 Division of General Surgery
- Fu Ouyang Division of General Surgery
- Fang-Ming Chen Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
10 participants
-
Global
310 participants
